Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (59)

Latest Posts

About This Stock More About This Stock
Investors Expecting Growth From Large Caps And M&A From Mid-Caps
Article By: Rod Raynovich
Tuesday, August 15, 2017 9:37 PM EDT
Biotech stocks in general have recovered from last week’s sell-off and remain in a monthly trend up despite a topping pattern from July. Despite weak seasonality and lack of M&A the sector is holding lows with good volume.
In this article: BMY, IBB, AMGN, CELG, GILD, XBI, XLV, ABBV, BLUE, FMI
Read
Hot Options Report: End Of Day - Wednesday, Aug 9
Article By: The Options Insider
Wednesday, August 9, 2017 9:44 PM EDT
Most active stock options for end of day Wednesday: AAPL, WFT, BMY and RAD.
In this article: BMY, RAD, WFT, AAPL
Read
Large Cap Biopharma Earnings Boost Stocks: Update Tuesday, Aug 1
Article By: Rod Raynovich
Tuesday, August 1, 2017 10:42 PM EDT
Stocks were broadly higher in July after financial reports. Now that earnings are in, track technicals and potential clinical catalysts for August/September which can be weak seasonally.
In this article: BMY, MBI, MRK, RHHBY, ALXN, IBB, REGN, AMGN, CELG, GILD, XBI, ABBV, BLUE, FMI, FBIOX, FBT
Read
Good Day Today: XBI Breaks Through To YTD Highs
Article By: Rod Raynovich
Monday, June 19, 2017 9:31 PM EDT
Tech stocks rebounded today and biotech stocks soared and maintained the market lead in 2017 performance.
In this article: BMY, ALNY, BMRN, INCY, QQQ, AMGN, CLVS, GILD, XBI, XLV, ICPT, BLUE, RDUS, IBB
Read
Rayno Life Science Portfolio 2017
Article By: Rod Raynovich
Saturday, June 17, 2017 11:22 AM EDT
Let's review Rayno Life Science Portfolio for 2017.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, GILD, HOLX, XBI, ABBV, BLUE, FMI
Read

PARTNER HEADLINES

Latest Tweets for $BMY

No tweets yet!